VISHEE(SH:688580) Xin Lang Cai Jing·2025-09-08 06:37Group 1 - The core viewpoint of the news is the performance and market position of Weisi Medical, which saw a stock price increase of 5.02% to 54.19 CNY per share, with a total market capitalization of 5.19 billion CNY [1] - Weisi Medical specializes in the research, production, and sales of rehabilitation medical devices, focusing on areas such as pelvic and postpartum rehabilitation, neurological rehabilitation, and mental rehabilitation [1] - The company's revenue composition includes magnetic stimulation products (39.44%), consumables and accessories (19.42%), electrophysiological products (19.18%), laser radiofrequency products (10.26%), electrical stimulation products (8.42%), and others (3.28%) [1] Group 2 - From the perspective of fund holdings, Weisi Medical is a significant investment for the Beixin Ruifeng Health Life Theme Flexible Allocation Fund, which reduced its holdings by 40,000 shares but still holds 90,000 shares, representing 4.68% of the fund's net value [2] - The Beixin Ruifeng Health Life Theme Flexible Allocation Fund has achieved a year-to-date return of 33.09% and a one-year return of 63.27%, ranking 1803 out of 8248 and 1504 out of 8051 in its category, respectively [2] - The fund manager, Pang Wenjie, has a tenure of over 5 years, with the best fund return during this period being 44.46% and the worst being -39.77% [3]